Stock PDEX PRO-DEX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pro-Dex, Inc.

Equities

PDEX

US74265M2052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 01:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
18.91 USD +1.61% Intraday chart for Pro-Dex, Inc. +6.36% +7.93%
02/05 Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M MT
02/05 Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19 MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 53.38 67.91 111.5 57.72 67.72 66.4 -
Enterprise Value (EV) 1 53.38 67.91 111.5 57.72 67.72 66.4 66.4
P/E ratio 13.4 x 11.9 x 27 x 15.6 x 9.79 x 37.8 x 13.7 x
Yield - - - - - - -
Capitalization / Revenue 1.96 x 1.95 x 2.93 x 1.37 x 1.47 x 1.34 x 1.3 x
EV / Revenue 1.96 x 1.95 x 2.93 x 1.37 x 1.47 x 1.34 x 1.3 x
EV / EBITDA 9.75 x 8.89 x 18.2 x 8.06 x 9.17 x 8 x 7.72 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book 3.21 x 3.56 x 5.55 x 2.45 x 2.17 x 2.09 x 1.89 x
Nbr of stocks (in thousands) 4,113 3,811 3,648 3,619 3,545 3,511 -
Reference price 2 12.98 17.82 30.56 15.95 19.10 18.91 18.91
Announcement Date 29/08/19 27/08/20 26/08/21 08/09/22 13/10/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025
Net sales 1 27.17 34.83 38.03 42.04 46.09 49.4 51
EBITDA 1 5.473 7.639 6.112 7.159 7.385 8.3 8.6
EBIT 1 4.998 7.066 4.525 5.158 5.762 6.5 7
Operating Margin 18.39% 20.28% 11.9% 12.27% 12.5% 13.16% 13.73%
Earnings before Tax (EBT) 1 5.447 7.902 5.626 4.706 9.428 2.3 6.5
Net income 1 4.148 6.112 4.45 3.855 7.074 1.8 5.2
Net margin 15.27% 17.55% 11.7% 9.17% 15.35% 3.64% 10.2%
EPS 2 0.9700 1.500 1.130 1.020 1.950 0.5000 1.380
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 29/08/19 27/08/20 26/08/21 08/09/22 13/10/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 10.17 9.265 12.62 11.09 11.28 13.08 10.64 11.94 12.59 14.29 10.6 12.5 12.7 14.6 11.2
EBITDA 1 2.059 1.572 1.727 1.35 1.499 2.481 2.055 2.303 1.261 2.701 2.1 2 2 2.4 2.1
EBIT 1 1.602 1.035 1.204 0.95 1.137 2.065 1.61 1.833 0.777 2.213 1.7 1.6 1.6 2 1.7
Operating Margin 15.75% 11.17% 9.54% 8.57% 10.08% 15.79% 15.13% 15.35% 6.17% 15.48% 16.04% 12.8% 12.6% 13.7% 15.18%
Earnings before Tax (EBT) 1 1.21 0.634 1.492 1.294 1.174 1.768 5.192 -0.829 0.62 0.913 1.6 1.5 1.5 1.9 1.6
Net income 1 0.925 0.462 0.641 1.076 0.879 1.313 3.806 -0.615 0.5 0.655 1.2 1.2 1.2 1.5 1.3
Net margin 9.09% 4.99% 5.08% 9.71% 7.79% 10.04% 35.77% -5.15% 3.97% 4.58% 11.32% 9.6% 9.45% 10.27% 11.61%
EPS 2 0.2500 0.1200 0.3700 0.2900 0.2400 0.3600 1.060 -0.1700 0.1400 0.1900 0.3500 0.3200 0.3200 0.4000 0.3300
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 03/02/22 05/05/22 08/09/22 03/11/22 02/02/23 04/05/23 13/10/23 02/11/23 08/02/24 02/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 4.050 5.000 5.510 6.510 8.780 9.060 10.00
Cash Flow per Share - - - - - - -
Capex 1 1.39 0.52 1.77 1.64 0.97 1.2 1.2
Capex / Sales 5.1% 1.49% 4.65% 3.9% 2.11% 2.43% 2.35%
Announcement Date 29/08/19 27/08/20 26/08/21 08/09/22 13/10/23 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Pro-Dex, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
18.91 USD
Average target price
28 USD
Spread / Average Target
+48.07%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PRO-DEX, INC. Stock Pro-Dex, Inc.
+7.93% 6.53Cr
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.82% 18TCr
MEDTRONIC PLC Stock Medtronic plc
+1.38% 11TCr
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.82% 6.81TCr
DEXCOM, INC. Stock DexCom, Inc.
+0.69% 5.05TCr
CENCORA, INC. Stock Cencora, Inc.
+8.54% 4.48TCr
HOYA CORPORATION Stock Hoya Corporation
+2.58% 4.07TCr
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+20.50% 3.23TCr
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.72% 2.65TCr
TERUMO CORPORATION Stock Terumo Corporation
+14.69% 2.5TCr
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PDEX Stock
  4. Financials Pro-Dex, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW